ADGRL1
protein-codingadhesion G protein-coupled receptor L1, the group of Adhesion G protein-coupled receptors, subfamily L
Gene summary
This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Latrophilins may function in both cell adhesion and signal transduction. In experiments with non-human species, endogenous proteolytic cleavage within a cysteine-rich GPS (G-protein-coupled-receptor proteolysis site) domain resulted in two subunits (a large extracellular N-terminal cell adhesion subunit and a subunit with substantial similarity to the secretin/calcitonin family of GPCRs) being non-covalently bound at the cell membrane. Latrophilin-1 has been shown to recruit the neurotoxin from black widow spider venom, alpha-latrotoxin, to the synapse plasma membrane. Alternative splicing results in multiple variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
- LPHN1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0859292
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859292
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*ADGRL1* encodes an adhesion G protein-coupled receptor, also known as latrophilin 1, which has been implicated in synaptic development, maturation, and activity. *ADGRL1* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2022 (Vitobello et al., PMID: 35907405). Clinical features observed in affected individuals include developmental delay, variable intellectual disability, autism spectrum disorder, attention-deficit/hyperactivity disorder, hypotonia, sleep disturbances, and mild facial dysmorphism. Less common findings include macrocephaly, overweight, joint hypermobility, and seizures. Thirteen variants (missense, nonsense, and frameshift) that have been reported in 8 probands in 1 publication (PMID: 35907405) and in 5 clinical laboratory submissions to ClinVar are included in this curation. In cases where parental testing was performed, the variants occurred *de novo*, except for 1 nonsense variant present in 2 affected siblings and inherited from the father with intellectual disability. *ADGRL1* is highly constrained for loss-of-function variants (pLI = 1, LOEUF = 0.28, gnomAD v4.1.1) and missense variants (Z score = 5.05). The mechanism of pathogenicity is reported to be loss of function (PMID: 35907405). This gene-disease relationship is also supported by experiments in cultured neurons showing that Adgrl1 is essential for the assembly of inhibitory synapses (PMID: 38684366). In summary, there is definitive evidence to support the relationship between *ADGRL1* and autosomal dominant complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 15, 2026 (SOP Version 12).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADGRL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014921.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 43 | 1 | 46 | ||
| missense | 3 | 4 | 293 | 20 | 320 | |
| nonsense | 5 | 11 | 6 | 22 | ||
| start loss | 0 | |||||
| frameshift | 7 | 6 | 16 | 29 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 13 | 17 | ||
| Total | 16 | 24 | 330 | 63 | 1 | 434 |
Highest pathogenic variant AF is 0.000003420726
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055736.2 | 22 | MANE Select | |
| Ensembl | ENSP00000355328.2 | 22 | MANE Select | |
| RefSeq | NP_001008701.1 | 23 | Standard | |
| Ensembl | ENSP00000340688.5 | 23 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GPCRs, Class B Secretin-like
Biological Process
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- calcium-mediated signaling using intracellular calcium source
Molecular Function
- G protein-coupled receptor activity
- protein binding
- latrotoxin receptor activity
- carbohydrate binding
- cell adhesion molecule binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- postsynaptic density
- integral component of membrane
- cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000340736
- Coding exons
- 23
- Length
- 56250
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.43 | 640 | 935 | 0.685 | 0.0000651 | 9410 |
| Missense (PolyPhen) | 235 | 433.4 | 0.54222 | 4243 | ||
| Synonymous | -1.72 | 470 | 425 | 1.11 | 0.0000323 | 3087 |
| Loss of Function | 6.99 | 7 | 70.3 | 0.0996 | 0.00000411 | 695 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0.000035 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium-independent receptor of high affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor for TENM2 that mediates heterophilic synaptic cell-cell contact and postsynaptic specialization. Receptor probably implicated in the regulation of exocytosis (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- RVIS EVS
- -2.63
- RVIS percentile EVS
- 0.8
Essentials
- Essential (gene trap)
- N